India's National Pharmaceutical Pricing Authority (NPPA) has raised the ceiling price of 11 essential drugs by 50% to ensure their availability. This decision was made under Paragraph 19 of the Drugs Prices Control Order due to increasing input costs and the threat of some manufacturers discontinuing supplies.